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CC BY-NC-ND license (http://creativeAbstract Solid pseudopapillary neoplasm (SPN) of the pancreas is a rare neoplasm that ac-
counts for 2e3% of all primary pancreatic neoplasms. This study aimed to characterize clinico-
pathological features associated with SPNs and to retrospectively evaluate the relationship of
these features with predictive parameters associated with aggressive behavior. We reviewed
16 cases of SPN of the pancreas that had been diagnosed between 2005 and 2014 at our pathol-
ogy department. A total of 16 cases, 15 female and one male, were evaluated in this study. The
patient age ranged from 13 years to 63 years with a median of 35.70 years. The mean tumor
diameter ranged from 2 cm to 18 cm with a mean diameter of 5.90 cm. We identified a signif-
icant association between the presence of clear cells and perineural invasion (pZ 0.019),
which was considered to be a predictive factor for aggressive behavior. Other features (i.e.,
localization, nuclear grooves, central hyalinization, myxoid stroma, eosinophilic bodies, foamy
histiocyte aggregates, multinucleated cells, and calcification) were not significantly associated
with predictive factors for aggressive behavior. One patient died as a result of a pancreatic fis-
tula that developed as a postoperative complication. The remaining 15 patients are alive and
have not demonstrated any signs of recurrence or metastasis. The current study suggested that
the presence of clear cells might serve as a possible prognostic indicator of perineural invasion,
which is a predictive parameter associated with aggressive behavior in SPN.
Copyright ª 2016, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. This is an
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Solid pseudopapillary neoplasm (SPN) of the pancreas is a
type of pancreatic neoplasm with low malignant potential,
and it represents 0.17e2.70% of all cases of pancreatic
tumors [1]. This tumor type was first reported by Frantz [2]
and was initially referred to by multiple names, including
solid papillary cystic tumor, cystic epithelial neoplasm, and
papillary cystic tumor, until the World Health Organization
(WHO) designated and reclassified them as SPNs in 2010 [3].
The nature and clinical behavior of these tumors remains
elusive. Pancreatic SPN is primarily observed in women and
has a peak incidence in patients aged 20e40 years [4]. Most
patients are asymptomatic and present incidentally with an
abdominal mass that is detected by radiological imaging,
and they exhibit levels of tumor markers within normal
limits. WHO reported that perineural invasion, pancreatic
paranchymal invasion, or lymphovascular invasion do not
remark increased malignant behavior, but predictive fac-
tors for aggressive behavior [3]. SPN metastasis is rare, and
in a recent study, some clinicopathological factors, such as
male gender, younger age, large tumor size (>5 cm), and
elevated mitotic rate are suggested to result in increased
malignant behavior [5e7]. The main objectives of this study
were to characterize clinicopathological features associ-
ated with SPNs and to retrospectively evaluate the rela-
tionship of these features with predictive parameters
associated with aggressive behavior.
Materials and methods
We reviewed the cases of 16 patients diagnosed with SPN of
the pancreas between the years 2005 and 2014 at our pa-
thology department (Bursa, Turkey). Two pathologists
reviewed and evaluated all the slides using light micro-
scopy. Information regarding histological and pathological
features, such as tumor size, presence of calcification,
central hyalinization, multinucleated cells, histiocytes,
nuclear grooves, clear cells, eosinophilic body, necrosis,
myxoid stroma, mitotic activity, presence of perineural,
lymphovascular, pancreatic parenchymal invasion, lymph
node involvement, and metastasis were collected.
Immunohistochemical study
Furthermore, for differential diagnosis (i.e., pancreatic
neuroendocrine neoplasms, adenocarcinoma, acinar cell
carcinoma) immunohistochemical study was performed.
Immunohistochemistry was carried out for a panel of
markers, including progesterone receptor (PR), CD10,
CD56, synaptophysin, CD57, chromogranin, epithelial
membrane antigen (EMA), cytokeratin AE1/AE3, and Ki67
on a Leica Bond Max automated slide stainer system (Leica,
Bannockburn, IL, USA). The primary antibodies used were
NCL-L-PGR-312 (Novocastra, Newcastle, UK; 1:150 dilution)
against PR, NCL-L-CD10-270 (Novocastra; 1:80 dilution)
against CD10, NCL-L-CD56-1B6 (Novocastra; 1:100 dilution)
against CD56, NCL-L-SYNAP-299 (Novocastra; 1:200) against
synaptophysin, Clone-NK1 (Lab Vision, Fremont, CA, USA;
1:100) against CD57, NCL-L-CHROM-430 (Novocastra; pre-
diluted) against chromogranin, NCL-L-EMA (Novocastra;1:400) against EMA, NCL-L-AE1/AE3 (Novocastra; 1:200)
against cytokeratin, and Clone SP6 (Lab Vision; 1:250)
against Ki-67.
Statistical analysis
Variables were expressed as the median (mini-
mumemaximum) or frequency. Between group comparisons
were performed using Fisher’s exact test. SPSS for Windows
version 21.0 (IBM Corp., Armonk, NY, USA) was used for
statistical analysis, and aZ 0.05 was considered statisti-
cally significant.
Results
Clinical data
We evaluated a total of 16 patients, 15 female and one
male, who were diagnosed with SPN of the pancreas at our
pathology department. The patient age ranged from 13
years to 63 years, with a median of 35.70 years. The most
frequently observed age range was 20e40 years. Nine pa-
tients were asymptomatic, and seven patients presented
with symptoms of abdominal pain or vomiting. Four pa-
tients had a medical history of diabetes mellitus and hy-
pertension. The tumors were located in the body or tail of
the pancreas in 10 patients (62.50%) and in the head of the
pancreas in six patients (37.50%). Serum tumor markers,
such as carbohydrate antigen 19.9, carcinoembryonic an-
tigen, and a-fetoprotein, were assayed. One patient with a
tumor located in the head exhibited elevated levels of
carbohydrate antigen 19-9 (73 U/mL; normal range  37 U/
mL). A preoperative diagnosis of SPN was made in four
patients (28.60%) based on the characteristic features
revealed by radiological imaging. Surgical procedures
included partial pancreatectomy in seven patients, distal
pancreatectomy in six patients, and pan-
creaticoduodenectomy (Whipple procedure) in three pa-
tients. Abdominal ultrasonography computed tomography
was used to evaluate patients during routine follow-up
visits. The patients were followed for a median of 28
months (range 10e72 months). One patient died as a result
of a pancreatic fistula that arose as a postoperative
complication. The other 15 patients are living and have not
demonstrated signs of recurrence or metastasis.
Pathological features
On a gross level, all of the tumors evaluated in this
study were encapsulated and well demarcated from
adjacent pancreas tissue. The mean diameter of the
tumors was 5.9 cm, ranging from 2 cm to 18 cm. A tumor
diameter > 5 cm was observed in seven (43.70%) cases,
and tumors < 5 cm were observed in nine cases
(56.30%).The cut surfaces of the tumors exhibited a
reddish-white, spongy appearance and demonstrated
signs of hemorrhaging.
Most tumors were composed of solid, cystic, and pseu-
dopapillary components. The nuclei of all tumor cells were
uniformly round and characteristic nuclear grooves were
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dominantly eosinophilic, but cells with a clear cytoplasm
were observed in seven cases (43.80%). Mitotic activity was
minimal (2/10 high-power fields). We observed various
features associated with degenerative changes, including
central hyalinization (4, 25%), myxoid stroma (5, 31.30%),
eosinophilic bodies (11, 68.80%), aggregates of foamy his-
tiocytes (6, 37.50%), multinucleated cells (6, 37.50%), and
calcification (4, 25%) (Figure 1).
In some cases, tumor cells exhibited signs that have
been linked to aggressive behavior [3]. Four cases (25%)
presented with perineural invasion. A tumor diameter >
5 cm was observed in seven (43.70%) cases. Pancreatic
parenchymal invasion was noted in 50% of the cases. Lym-
phovascular invasion, lymph node involvement, and
metastasis were not observed.
We next examined the relationship between patholog-
ical features and predictive factors for aggressive behavior
and identified a significant association between the pres-
ence of clear cells and perineural invasion (Figure 1;
pZ 0.019). Also, we found that there was a significant
relationship between central hyalinization and the pres-
ence of perineural invasion. The other pathological fea-
tures evaluated (i.e., localization, nuclear grooves, myxoid
stroma, eosinophilic bodies, foamy histiocytes aggregates,
multinucleated cells, and calcification) were not signifi-
cantly associated with predictive indicators of aggressive
behavior (Tables 1e3).Figure 1. Pathological features of SPN. (A) SPN of the pancreas
Tumor cells exhibit uniformly round nuclei, eosinophilic cytoplasm
100). (D) In the tumor, clear cells and perineural invasion are obs
pseudopapillary neoplasm.Immunohistochemical findings
The neoplastic cells in all cases were nuclear positive for PR
localization in the nucleus and diffusely positive for CD10
and CD56. Six cases (37%) exhibited focal synaptophysin
staining and CD57. Only two cases (12%) exhibited focal
chromogranin staining. Focal positive staining for epithelial
membrane antigen and cytokeratin AE1/AE3 was observed
in 37% and 50% of cases, respectively. The Ki67 proliferative
index ranged from 0% to 2%. Parameters of aggressive
behavior (i.e., perineural invasion, large tumor size, and
pancreatic parenchymal invasion) did not show any signifi-
cant association with all immunohistochemical markers
(Figure 2).Discussion
SPN of the pancreas is a rare neoplasm that accounts for
2e3% of all primary pancreatic neoplasms. This disease
predominantly affects young women, and it presents with
nonspecific symptoms such as abdominal pain, distension,
nausea, and vomiting [5,8]. The vast majority of cases in
this study were female (male: female ratio 1:15).
In the current study, SPN was most frequently observed
in the body or tail of the pancreas (62.50%). Previous
studies have reported that 19.50e73.30% of the tumors
evaluated were located in the body or tail of the pancreas,with characteristic pseudopapillary patterns (H&E, 100). (B)
(H&E, 200). (C). Tumor presents with clear cytoplasm (H&E,
erved (H&E, 200). H&EZ hematoxylin and eosin; SPNZ solid
Table 2 Histopathological features of patients with perineural invasion compared with patients without perineural invasion.
Without perineural invasion (nZ 12) With perineural invasion (nZ 4) p
Multinucleated cells (presence) 4 (33.30) 2 (50) 0.604
Calcification (presence) 2 (16.70) 2 (50) 0.245
Pancreatic parenchymal invasion
(presence)
4 (33.30) 4 (100) 0.077
Tumor size (5 cm) 6 (50) 1 (25) 0.585
Lymphovascular invasion (presence) 0 0 NA
Central hyalinization (presence) 1 (8.30) 3 (75) 0.027
Myxoid stroma (presence) 3 (25) 2 (50) 0.547
Clear cytoplasm (presence) 3 (25) 4 (100) 0.019
Eosinophilic cytoplasm (presence) 8 (66.70) 3 (75) >0.999
Aggregates of foamy histiocytes
(presence)
3 (25) 3 (75) 0.118
Data are presented as n (%).
NA Z Not Available (statistical analysis could not be performed because of insufficient sample size).
Table 3 Histopathological features of patients with pancreatic parenchymal invasion compared with patients without
pancreatic parenchymal invasion.
Without pancreatic
parenchymal invasion (nZ 8)
With pancreatic
parenchymal invasion (nZ 8)
p
Multinucleated cells (presence) 2 (25) 4 (50) 0.608
Calcification (presence) 2 (25) 2 (25) >0.999
Tumor size (5 cm) 6 (75) 1 (12.50) 0.041
Perineural invasion (presence) 0 4 (50) 0.077
Lymphovascular invasion (presence) 0 0 NA
Central hyalinization (presence) 0 4 (50) 0.077
Myxoid stroma (presence) 2 (25) 3 (75) >0.999
Clear cytoplasm (presence) 3 (37.50) 4 (50) >0.999
Eosinophilic cytoplasm (presence) 5 (62.50) 6 (75) >0.999
Aggregates of foamy histiocytes
(presence)
2 (25) 4 (50) 0.608
Data are presented as n (%).
NA Z Not Available (statistical analysis could not be performed because of insufficient sample size).
Table 1 Histopathological features of patients with tumor size > 5 cm compared with tumor size < 5 cm.
Tumor size < 5 cm (nZ 9) Tumor size  5 cm (nZ 7) p
Multinucleated cells (presence) 4 (44.40) 2 (28.60) 0.633
Calcification (presence) 3 (33.30) 1 (14.30) 0.585
Perineural invasion (presence) 3 (33.30) 1 (14.30) 0.585
Lymphovascular invasion (presence) 0 0 NA
Central hyalinization (presence) 4 (44.40) 0 0.088
Myxoid stroma (presence) 2 (22.20) 3 (42.90) 0.596
Clear cytoplasm (presence) 4 (44.40) 3 (42.90) >0.999
Eosinophilic cytoplasm (presence) 6 (66.70) 5 (71.40) >0.999
Aggregates of foamy histiocytes (presence) 3 (33.30) 3 (42.90) >0.999
Data are presented as n (%).
NA Z Not Available (statistical analysis could not be performed because of insufficient sample size).
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20e39.80% in the head; rates that are consistent with those
observed in this study [5e10].
Similar to other studies [6e9], the mean tumor size
evaluated in this study was 5.9 cm. However, a study ofpatients from Pakistan by Din et al [10] reported a mean
tumor size of 9.5 cm.
Macroscopically, all the tumors evaluated in this study
were encapsulated and well demarcated from the adjacent
non-tumor pancreatic tissue and they presented with large
Figure 2. Immunohistochemical findings. (A) SPN tumor cells stained intensely with membranous pattern for strong positivity of
CD56 (CD56, 100). (B) Positive reaction for CD10 in SPN tumor cells (CD10, 100). (C) Progesterone-receptor-positive nuclear
expression (PR, 100). (D) Ki-67 showing low cell proliferation index (Ki67, 100). H&EZ hematoxylin and eosin; SPNZ solid
pseudopapillary neoplasm.
360 N. Ugras et al.spongy areas at the cut surface indicative of hemorrhage
and solid and cystic degeneration. Similar macroscopic
features have been reported in other studies [1,5,10].
Most tumors were composed of solid, cystic and pseu-
dopapillary parts. The nuclei of all tumor cells were uni-
formly round, and characteristic nuclear grooves were
observed in seven cases (43.80%). The cytoplasm of the
tumor cells was predominantly eosinophilic, but clear cells
were observed in seven cases (43.80%). Various factors
associated with degeneration were observed, including
central hyalinization (4, 25%), myxoid stroma (5, 31.30%),
eosinophilic body (11, 68.80%), aggregates of foamy his-
tiocytes (6, 37.5%), multinucleated cells (6, 37.50%) and
calcification (4, 25%).
The neoplasms demonstrated relatively discrete micro-
scopic features. SPN cells demonstrated various combina-
tions of solid, cystic and pseudopapillary configurations. In
the cystic and cysticesolid components, one or several
layers of tumor cells discohesively covered the fibrovas-
cular cores and formed characteristic pseudopapilla [3,11].
Microscopically, the neoplasms were cellular and consisted
of regular-shaped, polygonal tumor cells that were uni-
formly round, and exhibited folded nuclei and abundant
cytoplasm. The cytoplasm of most cells is eosinophilic;
however, clear, basophilic and vacuolated cells are
observed in some cases [3]. Among the samples we evalu-
ated, seven (43.80%) tumors contained cells with a clear
cytoplasm. Ud Din et al [10] reported that clear cells wereobserved in 60% of the cases evaluated in their study. The
presence of nuclear grooves, another characteristic histo-
logical feature observed in SPN of the pancreas, was
observed in seven cases (43.80%) in this study. Degenerative
features, such as central hyalinization, myxoid stroma,
eosinophilic bodies, foamy histiocyte aggregates, multinu-
cleated cells, calcification, cholesterol clefts, and mucoid
degeneration, are also frequently observed [12,13].
SPN of the pancreas is a rare indolent neoplasm and is
associated with good prognosis. Studies that investigated
the clinicopathological features associated with malignant
behavior have reported different results [5e7,14,15]. Some
studies demonstrated that potentially malignant SPNs were
associated with larger tumor size [7,14,16] and vascular
invasion [7,15]. In another study, Chung et al [17] reported
that tumor size > 5 cm; elevated mitotic rate, presence of
lymphovascular, perineural, and pancreatic parenchymal
invasion, nuclear atypia may predict aggressive behavior,
similar to WHO report which the above- referred histo-
pathological factor of agressive behaviour. As none of the
cases in this study were considered malignant SPN (defined
as unresectable tumors, metastases, and disease recur-
rence), we only examined the relationship of pathological
features and predictive factors of aggressive behavior.
In this study, the clinical parameters and pathological
features evaluated were not significantly associated with
predictive factors of aggressive behavior in SPN. The only
significant association we identified was between the
Solid pseudopapillary neoplasm 361presence of clear cells and perineural invasion (pZ 0.019).
In 2006, Albores-Saavedra et al [18] first described
neoplastic SPN cells as large cytoplasmic empty vacuoles
and referred to a clear cell variant of SPN in three cases.
Hav et al [19] and Tanino et al [20] observed two cases of
this variant. In these reports, clear cell variant of SPN was a
histological variant based on >90% of the isolated
neoplastic cells containing large cytoplasmic empty vacu-
oles [18e20]. However, in this study, 20e25% of cells in
these cases were clear cells; therefore, they cannot be
considered clear cell variants of SPN. Similar to the results
in our study, Hav et al [19] evaluated and identified peri-
neural invasion in a case of clear cell SPN. Albores-Saavedra
et al [18] reported vascular invasion in one case of clear cell
variant of SPN. Tanino et al [20] did not observe perineural
invasion, vascular invasion, or increased mitotic activity in
clear cell SPN.
In conclusion, SPN of the pancreas is a rare indolent
neoplasm with low malignant potential, consistent with the
cases evaluated this study. The current study demonstrated
that the presence of clear cells might serve as a possible
prognostic indicator of perineural invasion, a feature
associated with aggressive behavior in SPN. The elusive
nature of SPN makes it an interesting neoplasm for clini-
cians and pathologists.References
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